Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Other Accumulated Expenses (2022 - 2024)

Historic Other Accumulated Expenses for Lucid Diagnostics (LUCD) over the last 3 years, with Q4 2024 value amounting to $869000.0.

  • Lucid Diagnostics' Other Accumulated Expenses fell 9069.49% to $869000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $869000.0, marking a year-over-year decrease of 9069.49%. This contributed to the annual value of $869000.0 for FY2024, which is 9069.49% down from last year.
  • According to the latest figures from Q4 2024, Lucid Diagnostics' Other Accumulated Expenses is $869000.0, which was down 9069.49% from $53000.0 recorded in Q3 2024.
  • In the past 5 years, Lucid Diagnostics' Other Accumulated Expenses registered a high of $10.3 million during Q3 2023, and its lowest value of $53000.0 during Q3 2024.
  • In the last 3 years, Lucid Diagnostics' Other Accumulated Expenses had a median value of $1.9 million in 2024 and averaged $3.9 million.
  • As far as peak fluctuations go, Lucid Diagnostics' Other Accumulated Expenses soared by 8828.63% in 2023, and later plummeted by 9948.47% in 2024.
  • Over the past 3 years, Lucid Diagnostics' Other Accumulated Expenses (Quarter) stood at $5.0 million in 2022, then skyrocketed by 88.29% to $9.3 million in 2023, then crashed by 90.69% to $869000.0 in 2024.
  • Its last three reported values are $869000.0 in Q4 2024, $53000.0 for Q3 2024, and $266000.0 during Q2 2024.